The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten
about
Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular toneFunctional and pathological roles of the 12- and 15-lipoxygenasesHigh glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathwayAngiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generationRole of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferationEffects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAsATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cellsInvolvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motilityMurine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's diseaseRole of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathiesProducts of 12/15-lipoxygenase upregulate the angiotensin II receptor.Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cellsOxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes.Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic NephropathyEffects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetesNovel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cellsRole of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy.Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats.Plasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs.Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels.Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells.G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes.
P2860
Q28248514-98101C25-004A-48ED-A2A6-B7C54BB32A83Q28296453-D3C67E5A-D898-4560-9DDB-A2A5663D02E5Q28567778-E56E7B80-F8FC-4E1F-B5AA-69C07ADF7837Q28571898-BAAF314A-993F-42B7-B11E-8D7C9A1982F9Q28572746-B112C8EA-4167-4AE7-A010-D1D779E0758CQ28574130-C01A43D4-25BD-4C87-96EC-3EE855B3EA76Q28581381-0FD26988-9D94-4AD8-912E-614209026B20Q28582121-5A89B8F0-7BE5-48E2-98DD-1C71BD9FC071Q30434202-3288D2CA-058D-4E85-B5A8-3A5803815322Q30434996-A4E40BCE-9752-4BA7-9E92-8857EE41E218Q30480611-E6F39F33-49B2-49B1-BE8D-AA84D41CE288Q34086993-B4268CE9-C5AE-4CD4-8EA8-B5E2FE902489Q34157216-128AB6F8-FFE2-4B5C-92FA-4F7F2FCCD8B9Q34343723-F6BBB22A-E14F-45D3-A712-337BB15C88DAQ34426173-9294C545-F05F-4B67-8054-EC85B57FE65CQ34434392-31C91FA3-7C61-43EE-B7DC-EF11DA97726EQ34464174-30FC8AD0-9547-49B1-B94D-01527960D59AQ34667363-88FA0331-C0BD-4FDB-AA73-EF52170B34FCQ34743589-BE2BDB17-FEC1-4C01-9FC8-58E7A78C69E9Q35083693-1F34D3AD-CBE5-44CA-8F23-28AC2FF9FFE1Q35707118-425D0EF5-600A-4533-82B0-FD96D8BACAFCQ35787438-6DB53FF9-460B-4D08-B5F6-279BF329A3B2Q35939806-680C06A6-1CF5-4C43-930E-EAC402C378A7Q36019900-0BCC5748-231F-486A-939D-4C70E039D0E1Q36174271-47F9A999-F304-40F9-B17A-18F8B10F3133Q36576553-60911A6C-B951-4E96-B57B-65B725190894Q36656799-82D5CACA-C6D9-4766-88B1-73818AC35574Q36844506-6484971B-D859-4601-A9D9-063C879620ECQ37149254-F343316E-5FA3-403D-88CC-8562C1BA37C9Q37168707-43FD03F5-DB64-415A-965B-63B047E0F3BDQ37257009-798D7EDC-78BF-4F4C-95DE-F19F98E937F2Q37306295-9AA2B71B-3143-4974-9C42-FE10C282DBF7Q38622658-5D75C68F-CF4A-4F21-8922-F98903860AA6Q40711499-753101B7-EEB1-4A29-A219-66C11B8606D5Q42510887-606C756B-4ECC-4924-9443-47EDDF6181A9Q42613234-4F6ECA52-6739-4F94-907E-69C9D0CBAEA2Q44011765-3A20A2DE-8276-4CCB-ABE1-9D84D14D0F1BQ44570733-0E0F1D27-AD17-40C9-BAA8-7C3F30179D98Q44746404-06CF5BC1-EB0F-4A18-B2B8-D4F4F17BB3F2Q45295556-85F770B8-1B23-4D17-931F-AF10CAA035AA
P2860
The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angioten
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
The oxidized lipid and lipoxygenase product 12
@nl
The oxidized lipid and lipoxyg ...... ivation. Mediation of angioten
@en
type
label
The oxidized lipid and lipoxygenase product 12
@nl
The oxidized lipid and lipoxyg ...... ivation. Mediation of angioten
@en
prefLabel
The oxidized lipid and lipoxygenase product 12
@nl
The oxidized lipid and lipoxyg ...... ivation. Mediation of angioten
@en
P2093
P2860
P356
P1476
The oxidized lipid and lipoxyg ...... ivation. Mediation of angioten
@en
P2093
Jerry L Nadler
Linda Lanting
Marpadga A Reddy
Pushpa-Rekha Thimmalapura
Rama Natarajan
Soghra Fatima
P2860
P304
P356
10.1074/JBC.M111305200
P407
P577
2002-01-10T00:00:00Z